Common Contracts
12 similar Release Agreement contracts by NovoCure LTD, Novocure LTD
January 4, 2024 Mr. Frank Leonard Novocure USA LLC Wayne, Pennsylvania 19087Release Agreement • January 4th, 2024 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this “Agreement”) are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability company (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Effective as of January 1, 2024 (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of May 3, 2023 (the “Prior Agreement”).
January 4, 2024 Mr. Pritesh Shah Novocure USA LLC New York, NY 10036 Dear Pritesh:Release Agreement • January 4th, 2024 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this “Agreement”) are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability company (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Effective January 1, 2024 (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of July 25, 2018 (the “Prior Agreement”).
May 3, 2023 Mr. Frank Leonard Novocure USA LLC Wayne, Pennsylvania 19087 Dear Frank:Release Agreement • May 4th, 2023 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this “Agreement”) are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability company (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date specified above (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of September 1, 2020 (the “Prior Agreement”).
April 1, 2022 Mr. Todd Longsworth Novocure USA LLC Portsmouth, NH 03801Release Agreement • April 7th, 2022 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purpose of this letter (this “Agreement”) is to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability company (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date specified above (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of February 3, 2017 (the “Prior Agreement”) and you acknowledge and agree that your execution and delivery of this Agreement does not constitute a termination of employment for “Good Reason” as defined in the Prior Agreement.
September 1, 2020Release Agreement • August 13th, 2020 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purpose of this letter (this “Agreement”) is to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability company (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date specified above (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of October 10, 2016 (the “Prior Agreement”) and you acknowledge and agree that your execution and delivery of this Agreement does not constitute a termination of employment for “Good Reason” as defined in the Prior Agreement.
September 1, 2020 Mr. Wilhelmus C.M. GroenhuysenRelease Agreement • August 13th, 2020 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this “Agreement”) are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability corporation (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date specified above (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of October 10, 2016 (the “Prior Agreement”).
September 1, 2020Release Agreement • August 13th, 2020 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this “Agreement”) are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability company (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date specified above (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of November 20, 2019 (the “Prior Agreement”).
July 16, 2018 Mr. Pritesh Shah Novocure USA LLC New York, NY 10036 Dear Pritesh:Release Agreement • October 25th, 2018 • NovoCure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this "Agreement") are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will transfer to Novocure USA LLC, a Delaware limited liability corporation (the "Company") and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the "Parent"). References herein to the "Novocure Group" shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date this Agreement is executed (the "Effective Date"), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of September 29, 2017 (the' Prior Agreement").
October 10, 2016 Mr. Michael J. Ambrogi 195 Commerce Way Portsmouth, NH 03801 Dear Michael:Release Agreement • October 14th, 2016 • Novocure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this “Agreement”) are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability company (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date this Agreement is executed (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of December 30, 2010 (the “Prior Agreement”).
Execution CopyRelease Agreement • October 14th, 2016 • Novocure LTD • Surgical & medical instruments & apparatus • New York
The purposes of this letter (this “Agreement”) are to amend and restate the terms and conditions of your Prior Agreement (as defined below) and to set forth and acknowledge certain terms of your continued employment with the Novocure Group. Your formal employment relationship will continue to be with Novocure USA LLC, a Delaware limited liability corporation (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date this Agreement is executed (the “Effective Date”), this Agreement will supersede and replace in its entirety the employment letter agreement between you and the Company, dated as of December 23, 2011 (the “Prior Agreement”).
May 11, 2016 Mr. William F. Doyle Novocure USA LLC New York, NY 10036 Dear Mr. Doyle:Release Agreement • May 13th, 2016 • Novocure LTD • Surgical & medical instruments & apparatus • New York
The purpose of this letter (this “Agreement”) is to set forth the terms of your employment with the Novocure Group. Your formal employment relationship will be with Novocure USA LLC, a Delaware limited liability corporation (the “Company”) and a wholly owned subsidiary of NovoCure Limited, a Jersey (Channel Islands) corporation (the “Parent”). References herein to the “Novocure Group” shall mean and refer to, collectively, the Parent, the Company and their respective direct and indirect subsidiaries and affiliates. Upon the date this Agreement is executed (the “Effective Date”), this Agreement will supersede and replace in its entirety that certain Consulting Services Agreement between you and the Parent, dated as of June 24, 2014, as amended by Amendment No. 1 to Consulting Services Agreement, dated as of September 16, 2015 and by Amendment No. 2 to Consulting Services Agreement, dated as of February 24, 2016 (collectively, the “Prior Agreement”).
December 30, 2010 Standen USA, Inc. 170 West Road, Unit #9 Portsmouth, New Hampshire 03801 Mr. Michael J. Ambrogi [ ] Dear Michael:Release Agreement • May 10th, 2016 • Novocure LTD • Surgical & medical instruments & apparatus • New York
The purpose of this letter (this “Agreement”) is to acknowledge and set forth the terms and conditions of your employment with the Novocure Group. Your formal employment relationship will be with Standen USA, Inc., a Delaware corporation (the “Company”) and a wholly owned subsidiary of Novocure Ltd., a Jersey Isle company (the “Parent”). All references in Section 7 below to the Company shall be deemed to refer to and include the Parent, the Company and all other subsidiaries of the Parent (collectively, the “Novocure Group”).
